Success Metrics

Clinical Success Rate
33.3%

Based on 2 completed trials

Completion Rate
33%(2/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
4(67%)

Phase Distribution

Ph phase_2
2
33%
Ph phase_3
4
67%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

2 of 6 finished

Non-Completion Rate

66.7%

4 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(2)
Terminated(4)

Detailed Status

Terminated4
Completed2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
33.3%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (33.3%)
Phase 34 (66.7%)

Trials by Status

completed233%
terminated467%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_2

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

NCT00131430
completedphase_2

A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)

NCT00109135
terminatedphase_3

An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)

NCT00384605
terminatedphase_3

An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)

NCT00430742
terminatedphase_3

A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)

NCT00131404
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00131430Phase 2

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

Completed
NCT00109135Phase 2

A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)

Completed
NCT00384605Phase 3

An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)

Terminated
NCT00430742Phase 3

An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)

Terminated
NCT00131404Phase 3

A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)

Terminated
NCT00420589Phase 3

A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)

Terminated

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6